×

Compositions and methods for modulating HBV expression

  • US 9,145,558 B2
  • Filed: 02/27/2015
  • Issued: 09/29/2015
  • Est. Priority Date: 05/01/2013
  • Status: Active Grant
First Claim
Patent Images

1. A compound comprising a modified oligonucleotide and a conjugate group, wherein the modified oligonucleotide consists of 20 contiguous nucleobases complementary to an equal length portion of nucleobases 1583 to 1602 of SEQ ID NO:

  • 1, wherein the nucleobase sequence of the modified oligonucleotide is 100% complementary to SEQ ID NO;

    1; and

    wherein the conjugate group comprises;

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×